http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019232138-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
filingDate 2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da26b9a2cb3e21c967f1dd1b7ddcbc1c
publicationDate 2019-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019232138-A1
titleOfInvention Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3) pyridazine-3-carboxamide
abstract Disclosed is crystalline Form B of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl) amino)-N-(methyl-d3)pyridazine-3-carboxamide. Form B is the HCl salt of a neat crystalline form. Characterization data for Form B are disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021055652-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022165141-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022212181-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021129467-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114787154-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021143498-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114787152-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023049241-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023023322-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021143430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022021684-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020251911-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022083649-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023076515-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021055651-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021202652-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023102085-A1
priorityDate 2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9505748-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408271913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413898522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430242094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450395493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134821691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411460056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422152937

Total number of triples: 57.